Elevance Health (NYSE:ELV) Stock Rating Upgraded by Argus
Argus upgraded Elevance Health from a “hold” rating to a “buy” rating and set a $450.00 price objective on the stock in a report on Monday.
Source link
Similar Posts
Massive upside: 8 largecap stocks set for up to 35% gains in 2026 – Add to Cart!
Analyst forecasts offer more than just numbers — they provide a strategic view of future market potential. For investors seeking the next big opportunity, a closer examination of BSE large-cap stocks highlights some promising contenders.Based on consensus estimates from Trendlyne, several large-cap stocks are projected to deliver strong returns over the next 12 months. This…
Retirees: 2 High-Yield Dividend Stocks to Own for TFSA Passive Income
Canadian pensioners are searching for ways to get better returns on their savings. One popular strategy involves owning high-yield TSX dividend stocks inside a self-directed Tax-Free Savings Account (TFSA). In the current environment, with markets at record highs, it makes sense to search for stocks that have long histories of delivering steady dividend growth during…
